1982
Immunological and physiological responses to whole-body hyperthermia.
Bull J, Lees D, Schuette W, Smith R, Glatstein E, DeVita V. Immunological and physiological responses to whole-body hyperthermia. National Cancer Institute Monograph 1982, 61: 177-81. PMID: 7177176.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsHot TemperatureHumansHydrocortisoneImmunityLeukocyte CountLymphocytesNeoplasmsVasoconstriction
1979
Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy.
Bull J, Lees D, Schuette W, Whang-Peng J, Smith R, Bynum G, Atkinson E, Gottdiener J, Gralnick H, Shawker T, DeVita V. Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Annals Of Internal Medicine 1979, 90: 317-23. PMID: 426399, DOI: 10.7326/0003-4819-90-3-317.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCardiovascular SystemEnzymesFemaleHot TemperatureHumansLeukocyte CountMaleMiddle AgedNeoplasmsConceptsWhole-body hyperthermiaBody hyperthermiaFlow-directed pulmonary artery catheterEvidence of cardiac damageCreatine phosphokinasePhase I trialPulmonary artery catheterAdjuvant to chemotherapySerum CPK valuesPhase I cancer trialsSystemic chemotherapyClotting abnormalitiesIntravenous analgesiaCardiac indexSerum magnesiumGranulocyte countAcute fallArtery catheterCardiac damageTransient elevationPeripheral neuropathyAcute riseArterial pHLiver enzymesWater-perfused suit
1976
Pneumocystis pneumonia in patients with cancer: clinical setting.
DeVita V, Goodell B, Hubbard S, Geelhoed G, Young R. Pneumocystis pneumonia in patients with cancer: clinical setting. National Cancer Institute Monograph 1976, 43: 41-7. PMID: 1087959.Peer-Reviewed Original ResearchConceptsPneumocystis pneumoniaClinical settingTreated with combination chemotherapyDevelopment of Pneumocystis pneumoniaWithdrawal of chemotherapyCombination chemotherapyClinical remissionHematologic malignanciesEmpirical treatmentSolid tumorsInfectious deathCancer patientsPatientsPentamidine isethionatePneumoniaAcute formChemotherapyTumorCancerRemissionUncontrolled growthMalignancyPneumocystis
1975
In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas.
Bull J, DeVita V, Carbone P. In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. Blood 1975, 45: 833-42. PMID: 1125431, DOI: 10.1182/blood.v45.6.833.bloodjournal456833.Peer-Reviewed Original ResearchConceptsHodgkin's diseaseMixed lymphomaUntreated patientsHistiocytic-lymphocytic lymphomasAdvanced Hodgkin's diseaseMOPP chemotherapyGranulocyte colony formationCombination chemotherapyMarrow culturesCFU-CIn vitro examinationLymphomaChemotherapyGranulocyte productionPatientsLong-term effectsAcute responseHodgkinColony formationDecreased numberDiseaseColony growthDibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.
Canellos G, Young R, Neiman P, DeVita V. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. Blood 1975, 45: 197-203. PMID: 1054609, DOI: 10.1182/blood.v45.2.197.bloodjournal452197.Peer-Reviewed Original ResearchConceptsTreatment of chronic granulocytic leukemiaBusulfan-treated patientsChronic granulocytic leukemiaGranulocytic leukemiaMedian duration of disease controlChronic phase of CGLDuration of disease controlContinuous maintenance therapyElevated leukocyte countTreated with busulfanIncreased skin pigmentationMyelosuppressive actionRemission inductionMaintenance therapyMedian survivalMedian durationBlastic transformationPulmonary fibrosisBusulfanRandomized comparisonChronic phaseLeukocyte countDibromomannitolPatientsCytological dysplasia
1974
Treatment of malignant melanoma with methyl CCNU
Young R, Canellos G, Chabner B, Schein P, Brereton H, DeVita V. Treatment of malignant melanoma with methyl CCNU. Clinical Pharmacology & Therapeutics 1974, 15: 617-622. PMID: 4601745, DOI: 10.1002/cpt1974156617.Peer-Reviewed Original Research
1972
Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.
Vogel C, Adamson R, DeVita V, Johns D, Kyalwazi S. Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma. Cancer Chemotherapy Reports 1972, 56: 249-58. PMID: 4339634.Peer-Reviewed Original ResearchDelayed hypersensitivity in Hodgkin's disease A study of 103 untreated patients
Young R, Corder M, Haynes H, DeVita V. Delayed hypersensitivity in Hodgkin's disease A study of 103 untreated patients. The American Journal Of Medicine 1972, 52: 63-72. PMID: 5058359, DOI: 10.1016/0002-9343(72)90008-3.Peer-Reviewed Original ResearchConceptsSkin test reactivityPeripheral lymphocyte countTest reactivityHodgkin's diseaseLymphocyte countUntreated patientsPrognostic signSkin testAbsolute peripheral lymphocyte countLymphocyte-depleted Hodgkin's diseaseMean absolute lymphocyte countIncidence of anergyStage IV diseaseAbsolute lymphocyte countBad prognostic signDuration of remissionFrequency of relapsesTime of diagnosisStage of diseaseUseful prognostic signCutaneous anergyPeripheral lymphocytopeniaMixed cellularityMumps antigenNodular sclerosis
1969
Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210.
DeVita V, Denham C, Perry S. Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210. Cancer Research 1969, 29: 1067-71. PMID: 5781099.Peer-Reviewed Original Research
1966
Pseudohyperkalemia Due to Release of Potassium from White Blood Cells during Clotting
Bronson W, DeVita V, Carbone P, Cotlove E. Pseudohyperkalemia Due to Release of Potassium from White Blood Cells during Clotting. New England Journal Of Medicine 1966, 274: 369-375. PMID: 5216594, DOI: 10.1056/nejm196602172740702.Peer-Reviewed Original Research